GlassScriptPhysician profile
Kurt M Solomon
NPI 1972552511
$1,214.68
in general payments reported to CMS, 2019-2025
15 companies · $595 in 2025
The $595 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $67.37 · 2021: $75.09 · 2022: $127 · 2023: $132 · 2024: $97.00 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $635.91 | 2020-2025 | Eylea Hd, Eylea |
| Biotissue Holdings INC. | $136.07 | 2025 | |
| Genentech USA, INC. | $95.71 | 2025 | Vabysmo |
| Aerie Pharmaceuticals, INC. | $53.28 | 2019 | |
| Novartis Pharmaceuticals Corporation | $42.41 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $40.54 | 2024-2025 | Miebo |
| Coopervision INC. | $38.62 | 2025 | Myday Contact Lens |
| Ani Pharmaceuticals, INC. | $28.15 | 2025 | Iluvien |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $27.26 | 2019 | |
| Eyepoint US, INC. | $24.61 | 2023 | |
| Harrow Eye, LLC | $22.29 | 2025 | Triesence |
| Apellis Pharmaceuticals, INC. | $21.95 | 2025 | Syfovre |
| Quidel Corporation | $16.79 | 2019 | |
| Abbvie INC. | $15.97 | 2025 | |
| Horizon Therapeutics Plc | $15.12 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.